Cargando…

Improved Early-Phase Insulin Response after Candesartan Treatment in Hypertensive Patients with Impaired Glucose Tolerance

As the effect of renin-angiotensin system (RAS) blockade on β-cells in clinical situations remains unclear, new evidence has been presented that angiotensin-converting enzyme (ACE) inhibitors and angiotensin ‖ receptor blockers (ARBs) may delay or prevent the development of insulin resistance and di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Katsunori, Nakagawa, Osamu, Aizawa, Yoshifusa
Formato:	Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2495588/ https://www.ncbi.nlm.nih.gov/pubmed/18633754 http://dx.doi.org/10.1080/10641960802269927

Ejemplares similares

Evaluation of Dosing Time-Related Anti-Hypertensive Efficacy of Valsartan in Patients with Type 2 Diabetes
por: Suzuki, Katsunori, et al.
Publicado: (2011)

Investigation of the introduction of three times daily injections of Insulin Lispro Mixture-50 on an outpatient basis: Therapeutic effects of 12 months’ treatment with and without concomitant sulfonylurea
por: Suzuki, Katsunori, et al.
Publicado: (2012)

Cost Effectiveness Analysis of Candesartan Therapy in Comparison to Candesartan-Amlodipine Therapy on Hypertensive Outpatients
por: Baroroh, Faridah, et al.
Publicado: (2019)

Effects of Insulin on Brain Glucose Metabolism in Impaired Glucose Tolerance
por: Hirvonen, Jussi, et al.
Publicado: (2011)

Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance
por: Aoyama-Sasabe, Sae, et al.
Publicado: (2016)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Sustained Decrease of Early-Phase Insulin Secretion in Japanese Women with Gestational Diabetes Mellitus Who Developed Impaired Glucose Tolerance and Impaired Fasting Glucose Postpartum
por: Katayama, Hiroko, et al.
Publicado: (2015)

Candesartan prevents impairment of recall caused by repeated stress in rats
por: Braszko, Jan Józef, et al.
Publicado: (2012)

Candesartan in heart failure
por: Ripley, Toni L, et al.
Publicado: (2006)

Reduced first-phase insulin secretion increases postprandial lipidemia in subjects with impaired glucose tolerance
por: Gómez-Sámano, Miguel Ángel, et al.
Publicado: (2017)

Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction
por: Okpechi, Ikechi G, et al.
Publicado: (2010)

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension
por: Granström, Ola, et al.
Publicado: (2012)

Natural History of Insulin Sensitivity and Insulin Secretion in the Progression From Normal Glucose Tolerance to Impaired Fasting Glycemia and Impaired Glucose Tolerance: The Inter99 Study
por: Færch, Kristine, et al.
Publicado: (2009)

Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study
por: Baguet, JP, et al.
Publicado: (2009)

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension
por: Kjeldsen, S E, et al.
Publicado: (2010)

Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS
por: Jeong, Hyeon-Cheol, et al.
Publicado: (2021)

Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease
por: Hajjar, Ihab, et al.
Publicado: (2022)

Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study
por: Sánchez-Rodríguez, Carmen, et al.
Publicado: (2021)

Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure
por: Sakamoto, Masaya, et al.
Publicado: (2012)

Insulin resistance, impaired glucose tolerance and alpha-thalassemia carrier state
por: Bahar, Adele, et al.
Publicado: (2015)

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
por: Kim, Jae Hyun, et al.
Publicado: (2014)

Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research)
por: Yang, Guang, et al.
Publicado: (2016)

Candesartan—the next anti-amyloid drug?
por: Yasar, Sevil
Publicado: (2022)

Insulin‐secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non‐obese Japanese patients
por: Iwahashi, Hiromi, et al.
Publicado: (2012)

Insulin secretion and insulin resistance in Korean women with gestational diabetes mellitus and impaired glucose tolerance
por: Yang, Sae Jeong, et al.
Publicado: (2013)

Impact of oral anticholinergic on insulin response to oral glucose load in patients with impaired glucose tolerance
por: Lahiry, Sandeep, et al.
Publicado: (2021)

Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive Drug
por: Aly, Usama Farghaly, et al.
Publicado: (2020)

PS221. Major depressive disorder and initial insulin hyposecretion in oral glucose tolerance test
por: Aizawa, E, et al.
Publicado: (2016)

Insulin Secretion and Its Determinants in the Progression of Impaired Glucose Tolerance to Type 2 Diabetes in Impaired Glucose-Tolerant Individuals: The Finnish Diabetes Prevention Study
por: de Mello, Vanessa D.F., et al.
Publicado: (2012)

Role of the Transcription Factor Sox4 in Insulin Secretion and Impaired Glucose Tolerance
por: Goldsworthy, Michelle, et al.
Publicado: (2008)

Prevalence of impaired glucose tolerance and insulin resistance among obese children and adolescents
por: Ghergherechi, Robabeh, et al.
Publicado: (2010)

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
por: Mengden, Thomas, et al.
Publicado: (2009)

Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension
por: Rakugi, Hiromi, et al.
Publicado: (2014)

Candesartan cilexetil in the treatment of chronic heart failure
por: Baguet, Jean-Philippe, et al.
Publicado: (2009)

Cardio classics revisited – focus on the role of candesartan
por: De Rosa, Maria Leonarda
Publicado: (2010)

Preparation of Candesartan and Atorvastatin Nanoparticles by Solvent Evaporation (†)
por: Vaculikova, Eliska, et al.
Publicado: (2012)

Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials
por: Henley, Brandon, et al.
Publicado: (2023)

Candesartan induces tumor vascular normalization to improve the efficacy of radiotherapy in the therapeutic window
por: Zhu, Fei, et al.
Publicado: (2022)

Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report
por: Suzuki, Hirofumi, et al.
Publicado: (2013)

Effects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance
por: Masuda, Kiyomi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mks6svtob0m7e48odoc9nj12bv